Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

29 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Pancreatic cancer in the older patient.
Jacobson SD, Alberts SR, O'Connell MJ. Jacobson SD, et al. Oncology (Williston Park). 2001 Jul;15(7):926-32; discussion 935-7. Oncology (Williston Park). 2001. PMID: 11499693 Free article. Review.
Phase 3 randomized trial of chemotherapy with or without oblimersen in older AML patients: CALGB 10201 (Alliance).
Walker AR, Marcucci G, Yin J, Blum W, Stock W, Kohlschmidt J, Mrózek K, Carroll AJ, Eisfeld AK, Wang ES, Jacobson S, Kolitz JE, Thakuri M, Sutamtewagul G, Vij R, Stuart RK, Byrd JC, Bloomfield CD, Stone RM, Larson RA. Walker AR, et al. Blood Adv. 2021 Jul 13;5(13):2775-2787. doi: 10.1182/bloodadvances.2021004233. Blood Adv. 2021. PMID: 34251414 Free PMC article. Clinical Trial.
CALGB 80802 (Alliance): Impact of Sorafenib with and without Doxorubicin on Hepatitis C Infection in Patients with Advanced Hepatocellular Carcinoma.
Abou-Alfa GK, Geyer SM, Nixon AB, Innocenti F, Shi Q, Kumthekar P, Jacobson S, El Dika I, Yaqubie A, Lopez J, Huang B, Tang YW, Wen Y, Schwartz LH, El-Khoueiry AB, Knox JJ, Rajdev L, Bertagnolli MM, Meyerhardt JA, O'Reilly EM, Venook AP. Abou-Alfa GK, et al. Cancer Res Commun. 2024 Mar 7;4(3):682-690. doi: 10.1158/2767-9764.CRC-22-0516. Cancer Res Commun. 2024. PMID: 38363156 Free PMC article. Clinical Trial.
Risk Factors for New Neurologic Diagnoses in Hospitalized Patients With COVID-19: A Case-Control Study in New York City.
Thakur KT, Chu VT, Hughes C, Kim CY, Fleck-Derderian S, Barrett CE, Matthews E, Balbi A, Bilski A, Chomba M, Lieberman O, Jacobson SD, Agarwal S, Roh D, Park S, Ssonko V, Silver WG, Vargas WD, Geneslaw A, Bell M, Waters B, Rao A, Claassen J, Boehme A, Willey JZ, Elkind MSV, Sobieszczyk ME, Zucker J, McCollum A, Sejvar J. Thakur KT, et al. Among authors: jacobson sd. Neurol Clin Pract. 2022 Aug;12(4):e66-e74. doi: 10.1212/CPJ.0000000000200006. Neurol Clin Pract. 2022. PMID: 36382116 Free PMC article.
A randomized double-blind controlled trial of convalescent plasma in adults with severe COVID-19.
O'Donnell MR, Grinsztejn B, Cummings MJ, Justman JE, Lamb MR, Eckhardt CM, Philip NM, Cheung YK, Gupta V, João E, Pilotto JH, Diniz MP, Cardoso SW, Abrams D, Rajagopalan KN, Borden SE, Wolf A, Sidi LC, Vizzoni A, Veloso VG, Bitan ZC, Scotto DE, Meyer BJ, Jacobson SD, Kantor A, Mishra N, Chauhan LV, Stone EF, Dei Zotti F, La Carpia F, Hudson KE, Ferrara SA, Schwartz J, Stotler BA, Lin WW, Wontakal SN, Shaz B, Briese T, Hod EA, Spitalnik SL, Eisenberger A, Lipkin WI. O'Donnell MR, et al. Among authors: jacobson sd. J Clin Invest. 2021 Jul 1;131(13):e150646. doi: 10.1172/JCI150646. J Clin Invest. 2021. PMID: 33974559 Free PMC article. Clinical Trial.
Correction to: Evaluating the efficacy and safety of human anti-SARS-CoV-2 convalescent plasma in severely ill adults with COVID-19: A structured summary of a study protocol for a randomized controlled trial.
Eckhardt CM, Cummings MJ, Rajagopalan KN, Borden S, Bitan ZC, Wolf A, Kantor A, Briese T, Meyer BJ, Jacobson SD, Scotto D, Mishra N, Philip NM, Stotler BA, Schwartz J, Shaz B, Spitalnik SL, Eisenberger A, Hod Jessica Justman EA, Cheung K, Lipkin WI, O'Donnell MR. Eckhardt CM, et al. Among authors: jacobson sd. Trials. 2020 Nov 17;21(1):927. doi: 10.1186/s13063-020-04877-z. Trials. 2020. PMID: 33203476 Free PMC article.
Correction to: Evaluating the efficacy and safety of human anti-SARS-CoV-2 convalescent plasma in severely ill adults with COVID-19: A structured summary of a study protocol for a randomized controlled trial.
Eckhardt CM, Cummings MJ, Rajagopalan KN, Borden S, Bitan ZC, Wolf A, Kantor A, Briese T, Meyer BJ, Jacobson SD, Scotto D, Mishra N, Philip NM, Stotler BA, Schwartz J, Shaz B, Spitalnik SL, Eisenberger A, Hod EA, Justman J, Cheung K, Lipkin WI, O'Donnell MR. Eckhardt CM, et al. Among authors: jacobson sd. Trials. 2020 Jun 16;21(1):536. doi: 10.1186/s13063-020-04504-x. Trials. 2020. PMID: 32546220 Free PMC article.
29 results